pharm-stream-recent-webinars
-
Building Oral Dosage Forms for Speed Today And Success Tomorrow
9/18/2026
Move toward the clinic with confidence using integrated development strategies that support smarter decisions and more efficient product development.
-
Improving Clinical Translation For ADCs And Immuno-Oncology With Human-Relevant Tumor Models
9/17/2026
When preclinical tumor models fail to reflect clinical reality, promising therapies pay the price. This webinar examines how advanced patient-derived organoids and 3D models improve predictive accuracy for ADC and immuno-oncology programs.
-
Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production
9/15/2026
Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.
-
Driving Productivity Across The Antibody Manufacturing Workflow
9/14/2026
Learn how integrated upstream and downstream strategies can reduce harvest bottlenecks, improve purification efficiency, and support scalable therapeutic antibody manufacturing.
-
The Next Generation Of USP <87> Testing
9/14/2026
Upcoming USP <87> changes are driving risk-based in vitro testing. Learn how to prepare for new requirements, validation impacts, and continued compliance.
-
De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing
9/11/2026
Explore practical approaches to scaling cell culture media manufacturing, from supply assurance to evolving quality requirements, digital formulation tools, and strategies for controlling costs.
-
How To Achieve Stable, High-Output Stickpack Production
9/9/2026
Explore practical ways to improve stickpack production through accurate dosing, reliable sealing, automated quality control, and efficient material handling while reducing complexity.
-
Beyond Breakdowns: Building A Culture Of Proactive Maintenance
9/8/2026
Reactive maintenance can drive costly downtime, deviations, and reliability challenges. Learn how proactive maintenance strategies help improve equipment uptime and strengthen compliance.
-
Overcome Early Development Challenges Before They Impact Your Program
9/3/2026
Poor manufacturability and immunogenicity can delay development. Learn how early developability assessments support IND readiness.
-
A CCS Is A Purpose-Built Machine, Not A Black Box: Understand The Workings
9/2/2026
Learn how to transform your contamination control strategy into a dynamic operational framework that identifies risks and strengthens facility control.